Skip to main content
Premium Trial:

Request an Annual Quote

Jackson ImmunoResearch Secures Non-Exclusive Rights to Thermo Fisher Fluorescent Dyes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced today that it has entered into a collaboration with Jackson ImmunoResearch Laboratories to facilitate the development of fluorescently labeled secondary antibodies for protein research and other applications.
 
Under the agreement, Jackson will have non-exclusive, global rights to use Thermo’s DyLight fluorescent dyes, which they plan to use in conjunction with Jackson’s secondary antibody line. The dyes are water-soluble, highly fluorescent, and photostable across a range of pH conditions.
 
Initially, Jackson plans to offer four of Thermo’s DyLight dyes conjugated to nearly 250 affinity-purified secondary antibodies, streptavidin, anti-biotin, anti-digoxin, anti-FITC, and purified immunoglobulins. The company is currently evaluating other DyLight dyes for potential use in its product line.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.